Duke University prevention Epicenter was given a grant of two million dollars by the Center for Disease Control and Prevention towards research work in the field of Healthcare-Associated Infections (HAI).
The Duke University has chosen the Tru-D germicidal disinfection system for the research after successful results in the internal trails. The University proposes to use five Tru-D instruments which will be deployed during the first two years of the grant.
The research program conducted by CDC’s Prevention Epicenters (PE) is a unique effort in which CDC’s Division of Healthcare Quality Promotion (DHQP) joins hands with academicians to study infection prevention and control methods. Thomas R. Frieden, the Director of CDC, sees PE’s as avenues to expand knowledge and move closer towards eliminating HAI’s.
John Jernigan, the director of CDC’s Office of HAI Prevention Research and evaluation, observed the trend over the last ten years has been that big breakthrough findings in infection prevention have come from PE’s, for e.g. the Tru-D Rapid Room Disinfection.
Articles that have been published so far on Tru-D treatment, enlist a number of environment pathogens that cause infections like MRSA, VRE, Acinetobactor, etc that can be destroyed using Tru-D disinfection treatment. The Tru-D technology has a distinguishing feature of determining the exact amount of disinfectant dose for each room and even showing the disinfection progress on a LCD screen.
Daniel Sexton, medical Director of Duke Infection Control Outreach Network (DICON), and his research team have chosen Tru-D system based on the grant amount. Tru-D’s disinfection capabilities have already been proven and therefore the team can do further research on how to prevent HAI’s through the aid of Tru-D.